Which is performing better right now, ABBV or JNJ?

Over the past month ABBV is +8.7% and JNJ is -4.4%, so ABBV is ahead on that window. Year to date the figures are +24.9% for ABBV and +23.5% for JNJ.

What are the key levels for ABBV and JNJ?

ABBV: resistance $300.00, support $275.00; JNJ: resistance $265.23, support $251.08. Levels come from recent swing zones and round numbers, recomputed daily.

When do ABBV and JNJ report next?

ABBV: 2026-10-30. JNJ: 2026-10-13. Earnings reset both the trend and the levels above, so a comparison made today is only good until the next report.

What does the ABBV/JNJ ratio mean?

It is simply ABBV's price divided by JNJ's — 1.1168 today. When the ratio rises, ABBV is outperforming; when it falls, JNJ is. Comparing it to its own 50- and 200-day averages shows whether the current leadership is new or long-standing.

ABBV vs JNJ

AbbVie Inc. against Johnson & Johnson — live side-by-side technical comparison.

Prices as of 2026-10-16T20:00:03+00:00 UTC · updates daily

Who leads right now

ABBV leads 4 of the 5 windows we measure — over 1 month ABBV is +8.7% and JNJ -4.4%; over year to date ABBV is +24.9% and JNJ +23.5%. The ABBV/JNJ price ratio stands at 1.1168, above its 50-day average of 0.9904, and above the 200-day average of 0.9581. A ratio above its own average means ABBV is gaining on JNJ; on this reading the recent edge belongs to ABBV.

Performance side by side

	ABBV	JNJ
Price	$285.42	$255.56
1 day	+0.7%	+0.9%lead
5 days	+3.2%lead	-2.2%
1 month	+8.7%lead	-4.4%
6 months	+36.6%lead	+9.0%
Year to date	+24.9%lead	+23.5%
52-week position	94% of range	74% of range
52-week range	$190.75–$291.40	$184.66–$281.07
vs 50-day average	above $262.45	below $265.23
vs 200-day average	above $233.95	above $244.12
RSI (14)	71	36
Next earnings	2026-10-30	2026-10-13

Where each one stands

ABBV — AbbVie Inc.

ABBV trades at $285.42, above its 50-day average of $262.45, and above the 200-day at $233.95. It sits at 94% of its 52-week range ($190.75–$291.40); 14-day RSI is 71, in overbought territory; an average session moves it about 2.4%. For levels, the first level overhead is $300.00 (5.1% away) and the first support below is $275.00 (3.6% down). On the checklist the page runs for every asset, 6 of 6 checks read bullish — the lean is bullish.

JNJ — Johnson & Johnson

JNJ trades at $255.56, below its 50-day average of $265.23, and above the 200-day at $244.12. It sits at 74% of its 52-week range ($184.66–$281.07); 14-day RSI is 36, in neutral territory; an average session moves it about 2.5%. For levels, the first level overhead is $265.23 (3.8% away) and the first support below is $251.08 (1.8% down). On the checklist the page runs for every asset, 2 of 6 checks read bullish — the lean is bearish.

Which one moves harder

Both move about the same amount day to day (2.4% and 2.5% of price), so the same position size carries comparable risk in either.

What would change the picture

The comparison turns on those levels: ABBV clearing $300.00 or losing $275.00; JNJ clearing $265.23 or losing $251.08. Until one of them gives way, the relative reading above stands.

Questions people ask about ABBV vs JNJ

Which is performing better right now, ABBV or JNJ?: Over the past month ABBV is +8.7% and JNJ is -4.4%, so ABBV is ahead on that window. Year to date the figures are +24.9% for ABBV and +23.5% for JNJ.
Is ABBV or JNJ more volatile?: Both move about the same amount day to day (2.4% and 2.5% of price), so the same position size carries comparable risk in either.
What are the key levels for ABBV and JNJ?: ABBV: resistance $300.00, support $275.00; JNJ: resistance $265.23, support $251.08. Levels come from recent swing zones and round numbers, recomputed daily.
When do ABBV and JNJ report next?: ABBV: 2026-10-30. JNJ: 2026-10-13. Earnings reset both the trend and the levels above, so a comparison made today is only good until the next report.
What does the ABBV/JNJ ratio mean?: It is simply ABBV's price divided by JNJ's — 1.1168 today. When the ratio rises, ABBV is outperforming; when it falls, JNJ is. Comparing it to its own 50- and 200-day averages shows whether the current leadership is new or long-standing.